首页> 美国卫生研究院文献>other >Patients’ Rights in Cross-border Healthcare (Directive 2011/24/EU) and How It Applies to Turkey as a Negotiating Candidate Country
【2h】

Patients’ Rights in Cross-border Healthcare (Directive 2011/24/EU) and How It Applies to Turkey as a Negotiating Candidate Country

机译:患者在跨境医疗保健中的权利(2011/24 / EU号指令)及其在土耳其作为谈判候选国的适用方式

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cross-border healthcare and patient mobility across European Union Member States has been on the agenda of EU Commission for the last decade. Directive 2011/24/EU on the application of patients’ rights in cross-border healthcare went into force in 2013. The Directive mainly addresses the responsibilities of Member States in cross-border healthcare, regulates reimbursement procedure, and coordinates European reference networks and health technology assessment in the EU. The Directive has direct and indirect implications on Turkish health system. In this article, first an overview of Directive 2011/24/EU is addressed with special attention to its relation to patient rights and other EU legislations. Then, Turkish citizens’ position in the scope of EU legislation on patient rights is considered. Finally, the ethical implications of the Directive, conceptualisation of cross-border patient mobility, and Turkey’s particular position among other candidate countries regarding cross-border healthcare is discussed.
机译:过去十年来,欧盟成员国之间的跨境医疗保健和患者流动一直是欧盟委员会的议程。关于患者权利在跨境医疗保健中应用的第2011/24 / EU号指令于2013年生效。该指令主要解决会员国在跨境医疗保健中的责任,规范报销程序,并协调欧洲参考网络和卫生欧盟的技术评估。该指令对土耳其的卫生系统有直接和间接的影响。在本文中,首先要对指令2011/24 / EU进行概述,并特别注意其与患者权利和其他欧盟法规的关系。然后,考虑土耳其公民在欧盟有关患者权利的立法范围内的立场。最后,讨论了该指令的伦理意义,跨境患者流动的概念化以及土耳其在其他候选国之间关于跨境医疗保健的特殊地位。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号